Renal dopamine receptors in health and hypertension

Pharmacology and Therapeutics

Volumn 80, Issue 2, 1998, Pages 149-182

  Jose, Pedro A ^a   Eisner, Gilbert M ^a   Felder, Robin A ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Dopamine; Dopamine receptors; Hypertension; Kidney; Na+ H+ exchanger; Na+K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; RECEPTOR SUBTYPE;

DOPAMINERGIC SYSTEM; ESSENTIAL HYPERTENSION; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0031769531     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00027-8     Document Type: Article

References (502)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93: 1945-1949.
2. Adam, W. R. (1979) Enhancement by L-DOPA of the renal action of aldosterone in the rat. Clin. Exp. Pharmacol. Physiol. 6: 87-96.
3. Adam, W. R. and Adams, B. A. (1985) Production and excretion of dopamine by the isolated perfused rat kidney. Renal Physiol. 8: 150-158.
4. Adam, W. R. and Goland, G. (1979) Dopamine and the enhanced renal response to aldosterone in the rat on a high potassium diet. Clin. Exp. Pharmacol. Physiol. 6: 631-635.
5. Adam, W. R., Culvenor, A. J., Hall, J., Jarrott, B. and Wellard, R. M. (1986) Aromatic L-amino acid decarboxylase: histochemical localization in rat kidney and lack of effect of dietary potassium or sodium loading on enzyme distribution. Clin. Exp. Pharmacol. Physiol. 13: 47-53.
6. Agnoli, G. C., Cacciari, M., Garutti, C., Ikonomu, E., Lenzi, P. and Marchetti, G. (1987) Effects of extracellular fluid volume changes on renal response to low-dose dopamine infusion in normal women. Clin. Physiol. 7: 465-479.
7. 1A receptor protein and messenger ribonucleic acid in rat adrenal cortex. Endocrinology 138: 1282-1288.
8. Akama, H., Noshiro, T., Sano, N., Watanabe, T., Trigg, L., Kotsonis, P., Majewski, H., McGrath, B. P., Miura, Y. and Abe, K. (1995) Effects of isotonic saline loading on renal tubular and neurogenic dopamine release in conscious rabbits. Clin. Exp. Pharmacol. Physiol. 22: 469-471.
9. Akpaffiong, M. J., Redfern, P. H. and Woodward, B. (1980) Factors affecting the release and excretion of dopamine in the rat. J. Pharm. Pharmacol. 32: 839-843.
10. Albrecht, F. E., Robillard, J. E., Eisner, G. M. and Jose, P. A. (1995) Receptor and G-protein regulation of the renal apical sodium/hydrogen exchanger (NHE) in genetic hypertension. Pediatr. Res. 37: 358A.
11. 1A dopamine receptor in the pathogenesis of genetic hypertension. J. Clin. Invest. 97: 2283-2288.
12. Alexander, R. W., Gill, J. R., Jr., Yamabe, H., Lovenberg, W. and Keiser, H. (1974) Effects of dietary sodium excretion and acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J. Clin. Invest. 54: 194-200.
13. 1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. J. Pharmacol. Exp. Ther. 238: 547-553.
14. Amemiya, M., Loffing, J., Lötsher, M., Kaissling, B., Alpern, R. J. and Moe, O. W. (1995) Expression of NHE-3 in the apical membrane of rat proximal tubule and thick ascending limb. Kidney Int. 48: 1206-1215.
15. Amenta, F. (1990) Density and distribution of dopamine receptors in the cardiovascular system and in the kidney. J. Auton. Pharmacol. 10 (Suppl. 1): S11-S18.
16. Amenta, F. (1997) Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin. Exp. Hypertens. 19: 27-41.
17. Amenta, F. and Ricci, A. (1990) Demonstration of dopamine DA-1 receptor sites in rat juxtaglomerular cells by light microscope autoradiography. Naunyn Schmiedebergs Arch. Pharmacol. 342: 719-721.
18. Andrejak, M. and Hary, L. (1986) Enhanced dopamine renal responsiveness in patients with hypertension. Clin. Pharmacol. Ther. 40: 610-614.
19. Antonipillai, I., Broers, M. I. and Land, D. (1989) Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release. Hypertension 13: 463-468.
20. +-2Cl cotransport and Na-K-ATPase in rat medullary thick ascending limb. Am. J. Physiol. 271: R1561-R1567.
21. +-ATPase activity in rat proximal convoluted tubule segments. Am. J. Physiol. 252: F39-F45.
22. Arendshorst, W. J. (1987) Altered reactivity of tubuloglomerular feedback. Annu. Rev. Physiol. 49: 295-317.
23. Armando, I., Nowicki, S., Aguirre, J. and Barontini, M. (1995) A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats. Am. J. Physiol. 268: F1087-F1092.
24. Arruda, J. A. L. and Sabatini, S. (1982) Dopaminergic inhibition of vasopressin-stimulated water flow in the toad bladder; evidence for local formation of dopamine. J. Memb. Biol. 68: 89-96.
25. Asico, L. D., Fuchs, S., Accili, D., Eisner, G. M. and Jose, P. A. (1997) Role of dopamine D3 receptors in the pathogenesis of genetic hypertension. Pediatr. Res. 41: 275A.
26. 1-dopamine receptor-mediated natriuresis. Clin. Exp. Hypertens. 20: 259-271.
27. Baines, A. D. (1982) Effects of salt intake and renal denervation on catecholamine catabolism and excretion. Kidney Int. 21: 316-322.
28. Baines, A. D. and Chan, W. (1980) Production of urine free dopamine from DOPA; a micropuncture study. Life Sci. 26: 253-259.
29. Baines, A. D. and Drangova, R. (1986) Neural but not tubular dopamine increases glomerular filtration rate in perfused rat kidneys. Am. J. Physiol. 250: F674-F679.
30. Baines, A. D., Drangova, R. and Hatcher, C. (1985) Dopamine production by isolated glomeruli and tubules from rat kidney. Can. J. Physiol. Pharmacol. 63: 155-158.
31. 86Rb uptake by renal proximal tubules. Am. J. Physiol. 258: F1133-F1138.
32. Baines, A. D., Ho, P. and Drangova, R. (1992) Proximal tubular dopamine production regulates basolateral Na-K-ATPase. Am. J. Physiol. 262: F566-F571.
33. Baldi, E., Pupill, C., Amenta, F. and Mannelli, M. (1988) Presence of dopamine-dependent adenylate cyclase activity in human renal cortex. Eur. J. Pharmacol. 149: 351-356.
34. Ball, S. G. and Lee, M. R. (1977) The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br. J. Clin. Pharmacol. 4: 115-119.
35. Ball, S. G., Oats, N. S. and Lee, M. R. (1978) Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin. Sci. Mol. Med. 55: 167-173.
36. Ball, S. G., Gunn, I. G. and Douglas, I. H. (1982) Renal handling of dopa, dopamine, norepinephrine and epinephrine in the dog. Am. J. Physiol. 242: F56-F62.
37. Barendregt, J. N. M., Muizert, Y., van Nispen tot Pannerden, L. A. and Chang, P. C. (1995a) Intrarenal production of dopamine and natriuresis following dopa and saline infusion in healthy human volunteers. J. Hum. Hypertens. 9: 187-194.
38. Barendregt, J. N. M., van Nispen tot Pannerden, L. A. and Chang, P. C. (1995b) Interactions between sodium balance, intrarenal dopamine synthesis, and sympathetic activity in HLA-identical kidney donors and recipients. Nephrol. Dial. Transplant. 10: 341-348.
39. 3 receptor in the rat kidney. Eur. J. Pharmacol. 338: 89-95.
40. 2-like receptors in the rat kidney: effect of denervation. Eur. J. Pharmacol. 334: 233-240.
41. Barnett, R., Singhal, P. C., Scharschmidt, L. A. and Schlondorff, D. (1986) Dopamine attenuates the contractile response to angiotensin II in isolated rat glomeruli and cultured mesangial cells. Circ. Res. 59: 529-533.
42. Barthelmebs, M., Caillete, A., Ehrhardt, J.-D., Velly, J. and Imbs, J.-L. (1990) Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney. Kidney Int. 37: 1414-1422.
43. Barthelmebs, M., Krieger, J. P., Grima, M. and Imbs, J.-L. (1991) Do renal vascular D2 receptors exist? Arch. Mal. Coeur. Vaiss. 84: 1211-1213.
44. Bass, A. S. and Robie, N. W. (1984) Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney. J. Pharmacol. Exp. Ther. 229: 67-71.
45. Beach, R. E. (1992) Renal nerve-mediated proximal tubule solute reabsorption contributes to hypertension in spontaneously hypertensive rats. Clin. Exp. Hypertens. 14: 685-697.
46. +-ATPase and solute transport in rabbit proximal tubules. Am. J. Physiol. 252: F215-F220.
47. Beguin, P., Beggah, A., Cotecchia, S. and Geering, K. (1996) Adrenergic, dopaminergic, and muscarinic receptor stimulation leads to PKA phosphorylation of Na-K-ATPase. Am. J. Physiol. 270: C131-C137.
48. Bell, C., Ferguson, M. and Petrovic, T. (1988) Neurochemistry of dopaminergic nerves. In: Peripheral Actions of Dopamine, pp. 41-45, Bell, C. and McGrath, B. (eds.) The MacMillan Press Ltd., London.
49. Bello-Reuss, E., Higashi, Y. and Kaneda, Y. (1982) Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am. J. Physiol. 242: F634-F640.
50. Bennett, E. D., Tighe, D. and Wegg, W. (1982) Abolition, by dopamine blockade, of the natriuretic response produced by lower-body positive pressure. Clin. Sci. 63: 361-366.
51. Berndt, T. J., MacDdonald, A., Walikonis, R., Chinnow, S., Dousa, T. P. and Knox, F. G. (1993) Excretion of catecholamines and metabolites in response to increased dietary phosphate intake. J. Lab. Clin. Med. 122: 80-84.
52. Berndt, T. J., Khraibi, A. A., Thothathri, V., Dousa, T. P., Tyce, G. M. and Knox, F. G. (1994) Effect of increased dietary phosphate intake on dopamine excretion in the presence and absence of the renal nerves. Miner. Electrolyte Metab. 20: 158-162.
53. Beron, J., Forster, I., Beguin, P., Geering, K. and Verrey, F. (1997) Phorbol 12-myristate 13-acetate down-regulates Na,K-ATPase independent of its protein kinase C site: decrease in basolateral surface area. Mol. Biol. Cell 8: 387-398.
54. +-ATPase activity from intact renal proximal tubule cells. J. Cell Sci. 101: 343-347.
55. +-ATPase is an effector protein for protein kinase C in renal proximal tubule cells. Am. J. Physiol. 256: F370-F373.
56. 2 receptors. Am. J. Physiol. 259: F924-F928.
57. +ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am. J. Physiol. 254: F795-F801.
58. 2 dopamine receptor synergism. Nature 347: 386-388.
59. +ATPase inhibits the activity of the enzyme. Proc. Natl. Acad. Sci. USA 88: 11359-11362.
60. Bhat, S., Churchill, M., Churchill, P. and McDonald, F. (1986) Renal effects of SK&F 82526 in anesthetized rats. Life Sci. 38: 1565-1571.
61. Biemesderfer, D., Rutherford, P. A., Nagy, T., Pizzonia, J. H., Abu-Alfa, A. K. and Aronson, P. S. (1997) Monoclonal antibodies for high resolution localization of NHE-3 in adult and neonatal rat. Am. J. Physiol. 273: F289-F299.
62. Blumberg, A. L., Dubb, J. W., Allison, N. L., Aldins, Z., Ramey, K. and Stote, R. M. (1988) Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans. J. Cardiovasc. Pharmacol. 11: 181-186.
63. Boren, K. R., Henry, D. P., Selkurt, E. E. and Weinberger, M. H. (1980) Renal modulation of urinary catecholamine excretion during volume expansion in the dog. Hypertension 2: 383-389.
64. + homeostasis in rat aorta smooth muscle cells. Am. J. Physiol. 272: C428-C438.
65. +)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626. Br. J. Pharmacol. 119: 1491-1497.
66. Braam, B., Mitchell, K. D., Koomans, H. A. and Navar, L. G. (1993) Relevance of the tubuloglomerular feedback mechanism in pathophysiology. J. Am. Soc. Nephrol. 4: 1257-1274.
67. Brayden, J. E. (1997) Potassium channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 23: 1069-1076.
68. Brooks, D. P. and Weinstock, J. (1991) The pharmacology of pramipexole in the spontaneously hypertensive rat. Eur. J. Pharmacol. 200: 339-341.
69. Brown, N. A. and Seabrook, G. R. (1995) Phosphorylation- and voltage-dependent inhibition of neuronal calcium currents by activation of human D2 (short) dopamine receptors. Br. J. Pharmacol. 115: 459-466.
70. Bryson, S. E., Drew, G. M., Hall, A. S., Ball, S. G. and Balmforth, A. J. (1992) Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture. Eur. J. Pharmacol. 225: 1-5.
71. Bughi, S., Horton, R., Antonipillai, I., Manoogian, C., Ehrlich, L. and Nadler, J. (1989) Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J. Clin. Endocrinol. Metab. 69: 1116-1121.
72. Bughi, S., Jost-Vu, E., Antonipillai, I., Nadler, J. and Horton, R. (1994) Effect of dopamine 2 blockade on renal function under varied sodium intake. J. Clin. Endocrinol. Metab. 78: 1079-1084.
73. Bühler, F. R. (1995) Antihypertensive care with calcium antagonists. In: Hypertension. Pathophysiology, Diagnosis and Management, pp. 2801-2814, Laragh, J. H. and Brenner, B. M. (eds.) Raven Press, New York.
74. 2 dopamine receptor cDNA. Nature 336: 783-787.
75. 1B dopamine receptors in rat kidney. Soc. Neurosci. Abstr. 19: 75.
76. Cadnapaphornchai, P., Taher, S. M. and McDonald, F. D. (1977) Mechanism of dopamine-induced diuresis in the dog. Am. J. Physiol. 232: F524-F528.
77. Cantrell, A. R., Smith, R. D., Goldin, A. L., Scheuer, T. and Catterall, W. A. (1997) Dopaminergic modulation of sodium current in hippocampal neurons via cAMP-dependent phosphorylation of specific sites in the sodium channel α subunit. J. Neurosci. 17: 7330-7338.
78. Carey, R. M. and Sen, S. (1986) Recent progress in the control of aldosterone secretion. Recent Prog. Horm. Res. 42: 251-296.
79. Carey, R. M., Van Loon, G. R., Baines, A. D. and Ortt, E. M. (1981) Decreased plasma and urinary dopamine during dietary sodium depletion in man. J. Clin. Endocrinol. Metab. 52: 903-909.
80. Carey, R. M., Stote, R. M., Dubb, J. W., Townsend, L. H., Rose, E. D., Jr. and Kaiser, D. L. (1984) Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension. J. Clin. Invest. 74: 2198-2207.
81. +-ATPase α-subunit in rat kidney cortical tubules. Am. J. Physiol. 271: C136-C143.
82. +-ATPase alpha-subunit phosphorylation by a cAMP-dependent signalling pathway in intact cells from rat kidney cortex. FEBS Lett. 396: 309-314.
83. +-ATPase activity by increasing pump units number at the cell surface of rat proximal convoluted tubule. J. Am. Soc. Nephrol. 8: 30A.
84. Chan, T. Y., Critchley, J. A., Ho, C. S., Chan, J. C. and Tomlinson, B. (1996) Urinary dopamine outputs do not rise in healthy Chinese subjects during gradually increasing oral sodium intake over 8 days. J. Auton. Pharmacol. 16: 155-159.
85. Chan, Y. L. (1976) Cellular mechanisms of renal tubular transport of L-DOPA and its derivatives in the rat: microperfusion studies. J. Pharmacol. Exp. Ther. 199: 17-24.
86. Chan, Y. L., Chatsudthipong, V., Su-Tsai, S. M. and von Riotte, A. (1986) The role of calcium in the dopaminergic effect on the proximal convoluted tubule of rat kidney. Fed. Proc. 45: 508.
87. Chatziantoniou, C., Ruan, X. and Arendshorst, W. J. (1995) Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. Natl. Acad. Sci. USA 92: 2924-2928.
88. Chen, C. and Lokhandwala, M. F. (1992) An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 14: 615-628.
89. +ATPase activity in rat renal proximal tubules by dopamine involved DA-1 receptor activation. Naunyn Schmiedebergs Arch. Pharmacol. 347: 289-295.
90. Chen, C. and Lokhandwala, M. F. (1995) Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn Schmiedebergs Arch. Pharmacol. 352: 194-200.
91. Chen, C. C. and Wu, M. L. (1995) Protein kinase C isoform delta is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cells. Mol. Pharmacol. 48: 995-1003.
92. Chen, C.-J., Apparsundaram, S. and Lokhandwala, M. F. (1991) Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J. Pharmacol. Exp. Ther. 256: 486-491.
93. Chen, C.-J., Vyas, S. J., Eichberg, J. and Lokhandwala, M. F. (1992) Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats. Hypertension 19: 102-108.
94. Chen, C., Beach, R. E. and Lokhandwala, M. F. (1993) Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21: 364-372.
95. Cheng, H.-F., Becker, B. N. and Harris, R. C. (1996) Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Invest. 97: 2745-2752.
96. Cheng, H.-F., Wang, J.-L., Vinson, G. P. and Harris, R. C. (1998) Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule. Am. J. Physiol. 274: F10-F17.
97. Cheng, L., Precht, P., Frank, D. and Liang, C. T. (1990) Dopamine stimulation of cAMP production in cultured opossum kidney cells. Am. J. Physiol. 258: F877-F882.
98. +-ATPase (NKA). J. Am. Soc. Nephrol. 8: 31A.
99. +-ATPase in response to β-adrenergic hormone. Am. J. Physiol. 273: C893-C901.
100. Chibalin, A. V., Pedemonte, C., Katz, A. I., Féraille, E. and Bertorello, A. M. (1997a) Dopamine-dependent endocytosis of Na,K-ATPase is triggered by PKC-mediated phosphorylation of the catalytic α-subunit. J. Am. Soc. Nephrol. 8: 59A.
101. Chibalin, A. V., Pedemonte, C., Katz, A. I., Owada, S., Ogimoto, G., Féraille, E. and Bertorello, A. M. (1997b) Na,K-ATPase α-subunits internalized in response to dopamine are dephosphorylated in late endosomes. J. Am. Soc. Nephrol. 8: 435A.
102. Chio, C. L., Hess, G. F., Graham, R. S. and Huff, R. M. (1990) A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus. Nature 343: 266-269.
103. Chuang, T. T., lacovelli, L., Sallese, M. and De Blasi, A. (1996) G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17: 416-421.
104. Clark, B. A., Rosa, R. M., Epstein, F. H., Young, J. B. and Landsberg, L. (1992) Altered dopaminergic responses in hypertension. Hypertension 19: 589-594.
105. 1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in anesthetized dogs. J. Hypertens. 9: 1143-1150.
106. Cohen-Luria, R., Moran, A. and Rimon, G. (1994) Cyclooxygenase inhibitors suppress inhibitory effect of PGE2 on Na-K-ATPase in MDCK cells. Am. J. Physiol. 267: F94-F98.
107. Cole, J. A., Eber, S. L., Poelling, R. E., Thorne, P. K. and Forte, L. R. (1987) A dual mechanism for regulation of kidney phosphate transport by parathyroid hormone. Am. J. Physiol. 253: E221-E227.
108. Cooper, D. M., Mons, N. and Karpen, J. W. (1995) Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374: 421-424.
109. Cooper, J. R., Bloom, F. E. and Roth, R. H. (1996) The Biochemical Basis of Neuropharmacology, 7th edn. Oxford University Press, New York.
110. Coruzzi, P., Biggi, A., Musiari, L., Ravanetti, C., Vescovi, P. P. and Novarini, A. (1986) Dopamine blockade and natriuresis during water immersion in normal man. Clin. Sci. 70: 523-526.
111. Cuche, J. L. (1988) Sources of circulating dopamine: a personal view. In: Peripheral Actions of Dopamine, pp. 1-23, Bell, C. and McGrath, B. (eds.) The MacMillan Press Ltd., London.
112. Cuche, J. L., Marchand, G. R., Greger, R. F., Lang, R. C. and Knox, F. G. (1976) Phosphaturic effect of dopamine in dogs. Possible role of intrarenally produced dopamine in phosphate regulation. J. Clin. Invest. 58: 71-76.
113. Cuche, J. L., Selz, F., Ruget, G., Jondeau, G. and Guedon, J. (1983) Is dopamine a physiological natriuretic hormone in the dog? Clin. Sci. 65: 479-486.
114. 2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8: 4025-4034.
115. Dazai, Y., Iwata, T. and Hiwada, K. (1993) Augmentation of the renal tubular dopaminergic activity by oral calcium supplementation in patients with essential hypertension. Am. J. Hypertens. 16: 933-937.
116. 1 dopamine receptor. Nature 347: 72-76.
117. Debska-Slizien, A., Ho, P., Drangova, R. and Baines, A. D. (1994a) Endogenous renal dopamine production regulates phosphate excretion. Am. J. Physiol. 266: F858-F867.
118. Debska-Slizien, A., Ho, P., Drangova, R. and Baines, A. D. (1994b) Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J. Am. Soc. Nephrol. 5: 1125-1132.
119. Deis, R. P. and Alonso, N. (1970) Diuretic effect of dopamine in the rat. J. Endocrinol. 47: 129-130.
120. Demchyshyn, L. L., Sugamori, K. S., Lee, F. J. S., Hamadanizadeh, S. A. and Niznik, H. B. (1995) The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptors from Gallus domesticus. J. Biol. Chem. 270: 4005-4012.
121. DiBona, G. F. and Kopp, U. C. (1997) Neural control of renal function. Physiol. Rev. 77: 75-197.
122. 2 receptor by protein kinase C. J. Neurosci. 13: 4846-4853.
123. Dinnerstein, R. J., Vannice, J., Henderson, R. C., Roth, L. J., Goldberg, L. I. and Hoffmann, P. C. (1979) Histofluorescence techniques provide evidence for dopamine containing neuronal elements in the canine kidney. Science 205: 497-499.
124. Donowitz, M., Elta, G., Battisti, L., Fogel, R. and Label-Schwartz, E. (1983) Effect of dopamine and bromocriptine on rat ileal and colonic transport. Stimulation of absorption and reversal of cholera toxin-induced secretion. Gastroenterology 84: 516-523.
125. Dupont, A. G., Vanderniepen, P., Lefebvre, R. A. and Bogaert, M. G. (1986) Pharmacological characterization of neuronal dopamine receptors in the rat hindquarters, renal and superior mesenteric vascular beds. J. Auton. Pharmacol. 6: 305-319.
126. Edwards, R. M. (1985) Response of isolated arterioles to acetylcholine, dopamine and bradykinin. Am. J. Physiol. 248: F183-F189.
127. Edwards, R. M. (1986) Comparison of the effects of fenoldopam, SK&F R-87516 and dopamine on renal arterioles in vitro. Eur. J. Pharmacol. 126: 167-170.
128. Eisner, G. M., Yamaguchi, I., Felder, R. A., Asico, L. D. and Jose, P. A. (1994) Role of renal dopamine-1 receptors in the natriuresis induced by calcium channel blockers. Am. J. Physiol. 267: F965-F970.
129. Eisner, G. M., Asico, L. D. and Jose, P. A. (1997) Dopamine and diltiazem-induced natriuresis in the spontaneously hypertensive rat. Am. J. Physiol. 273: R317-R323.
130. +-ATPase. Kidney Int. 52: 742-747.
131. Faucheux, B., Buu, N. T. and Kuchel, O. (1977) Effects of saline and albumin on plasma and urinary catecholamines in dogs. Am. J. Physiol. 232: F123-F127.
132. Felder, C. C., Blecher, M. and Jose, P. A. (1989a) Dopamine-1 mediated stimulation of phospholipase C activity in rat renal cortical membranes. J. Biol. Chem. 264: 8739-8745.
133. Felder, C. C., Jose, P. A. and Axelrod, J. (1989b) The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J. Pharmacol. Exp. Ther. 248: 171-175.
134. Felder, C. C., McKelvey, A. M., Gitler, M. S., Eisner, G. M. and Jose, P. A. (1989c) Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int. 36: 183-193.
135. Felder, C. C., Albrecht, F., Eisner, G. M. and Jose, P. A. (1990a) The signal transducer for dopamine-1 regulated sodium transport in renal cortical brush border membrane vesicles. Am. J. Hypertens. 3: 47S-50S.
136. +-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am. J. Physiol. 259: F297-F303.
137. +/H+ exchange activity in renal cortical brush border membranes by dopamine-1 agonists. Am. J. Physiol. 264: F1032-F1037.
138. 125ISch 23982. Am. J. Physiol. 255: F970-F976.
139. Felder, R. A. and VanCampen, M. (1990) Differential modulation of the renal proximal tubular DA-1 receptor by Gpp(NH)p and sodium in the spontaneously hypertensive rat. J. Auton. Pharmacol. 10 (Suppl. 1): s61-s65.
140. Felder, R. A., Blecher, M., Calcagno, P. L. and Jose, P. A. (1984a) Dopamine receptors in the proximal tubule of the rabbit. Am. J. Physiol. 247: F499-F505.
141. Felder, R. A., Blecher, M., Eisner, G. M. and Jose, P. A. (1984b) Cortical tubular and glomerular dopamine receptors in the rat kidney. Am. J. Physiol. 246: F557-F568.
142. Felder, R. A., Felder, C. C., Eisner, G. M. and Jose, P. A. (1988a) Renal dopamine receptors. In: Peripheral Actions of Dopamine, pp. 124-140, Bell, C. and McGrath, B. (eds.) MacMillan Press, Ltd., London.
143. Felder, R. A., Nakamura, K. T., Robillard, J. E., Kanadjian, M. and Jose, P. A. (1988b) Dopamine receptors in the developing sheep kidney. Pediatr. Nephrol. 2: 156-162.
144. Felder, R. A., Felder, C. C., Eisner, G. M. and Jose, P. A. (1989) The dopamine receptor in adult and maturing kidney. Am. J. Physiol. 257: F315-F327.
145. Felder, R. A., Kinoshita, S., Sidhu, A., Ohbu, K. and Kaskel, F. J. (1990a) A renal dopamine-1 receptor defect in two genetic models of hypertension. Am. J. Hypertens. 3: 96S-99S.
146. Felder, R. A., Seikaly, M. G., Cody, P., Eisner, G. M. and Jose, P. A. (1990b) Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569.
147. 1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am. J. Physiol. 264: R726-R732.
148. +-ATPase in rat proximal convoluted tubules. Am. J. Physiol. 268: C1277-C1283.
149. Féraille, E., Carranza, M. L., Béguin, P., Rousselot, M. and Favre, H. (1997) PKA phosphorylation stimulates Na,K-ATPase activity through recruitment of active pump units in plasma membrane. J. Am. Soc. Nephrol. 8: 32A.
150. Ferguson, S. G., Barak, L. S., Zhang, J. and Caron, M. G. (1996) G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74: 1095-1110.
151. Feschenko, M. S. and Sweadner, K. J. (1994) Conformational dependent phosphorylation of Na,K-ATPase by protein kinase A and protein kinase C. J. Biol. Chem. 269: 30436-30444.
152. Feschenko, M. S. and Sweadner, K. J. (1995) Structural basis for species-specific differences in the phosphorylation of Na,K-ATPase by protein kinase C. J. Biol. Chem. 270: 14072-14077.
153. Feschenko, M. S. and Sweadner, K. J. (1997) Phosphorylation of Na,K-ATPase by protein kinase C at Ser 18 occurs in intact cells but does not result in inhibition of ATP hydrolysis. J. Biol. Chem. 272: 17726-17733.
154. + ATPase and effects of site-directed mutagenesis. J. Biol. Chem. 269: 9368-9373.
155. + ATPase in the choroid plexus. Regulation by serotonin/protein kinase pathway. J. Biol. Chem. 270: 2427-2430.
156. 1 antagonist SCH 23390. Am. J. Physiol. 249: F236-F240.
157. 3 dopamine receptors. J. Pharmacol. Exp. Ther. 268: 417-426.
158. Friedman, E., Jin, L. Q., Cai, G.-P., Hollon, T. R., Drago, J., Sibley, D. R. and Wang, H. Y. (1997) D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice. Mol. Pharmacol. 51: 6-11.
159. 2 subfamily of dopamine receptor genes in the kidney. Am. J. Physiol. 266: F646-F650.
160. + pump in guinea-pig ventricular myocytes. J. Physiol. 449: 689-704.
161. + pump current in guinea-pig ventricular myocytes by a cAMP-dependent PKA pathway. J. Physiol. 477: 373-380.
162. Gao, Y. J., Nishimura, Y. and Suzuki, A. (1995) Dopamine-induced relaxation in isolated intrarenal arteries from adult stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 22 (Suppl. 1): S96-S98.
163. Garcia, N. H., Berndt, T. J. and Knox, F. G. (1997) L-DOPA administration increases phosphate excretion in the remnant kidney (RK) rats by increasing dopamine and decreasing serotonin. J. Am. Soc. Nephrol. 8: 561A.
164. 2-dopamine receptor and substance P genes in the carotid body of the rat. Neuroscience 75: 969-977.
165. + exchanger. Am. J. Physiol. 258: F514-F521.
166. + exchanger in spontaneously hypertensive rats. Am. J. Physiol. 261: F526-F536.
167. Gill, J. R., Jr., Gullner, H. G., Lake, C. R., Lakatua, D. J. and Lan, G. (1988) Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 11: 312-319.
168. Gill, J. R., Jr., Grossman, E. and Goldstein, D. S. (1991) High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension 18: 614-621.
169. Gingrich, J. A. and Caron, M. G. (1993) Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16: 299-321.
170. Girbes, A. R., Smit, A. J., Meijer, S. and Reitsma, W. D. (1990) Renal and endocrine effects of fenoldopam and metoclopramide in normal man. Nephron 56: 179-185.
171. 2 dopamine receptor isoforms. Nature 342: 923-929.
172. 3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Commun. 175: 1584-1591.
173. +-phosphate cotransport by dopamine. Am. J. Physiol. 264: F618-F622.
174. Glase, S. A., Akunne, H. C., Georgic, L. M., Heffner, T. G., MacKenzie, R. G., Manley, P. J., Pugsley, T. A. and Wise, L. D. (1997) Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists. J. Med. Chem. 40: 1771-1772.
175. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol. Exp. Ther. 275: 899-913.
176. Goldberg, L. I. (1972) Cardiovascular and renal actions of dopamine. Pharmacol. Rev. 24: 1-29.
177. Goldberg, L. I., Kohli, J. D. and Litinsky, J. J. (1979) Comparison of peripheral pre- and post-synaptic dopamine receptors. In: Presynaptic Receptors, pp. 37-41, Langer, S. Z., Starke, K. and Dubocovich, M. L. (eds.) Pergamon Press, New York.
178. Goldberg, L. I., Kohli, J. D. and Glock, D. (1986) Conclusive evidence for two subtypes of peripheral dopamine receptors. In: Dopaminergic Systems and Their Regulation, pp. 195-212, Woodruff, G. N., Poat, J. A. and Roberts, P. J. (eds.) The MacMillan Press Ltd., London.
179. Goldstein, D. S., Stull, R., Eisenhofer, G. and Gill, J. R., Jr. (1989) Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin. Sci. 76: 517-522.
180. +)-ATPase activity in rat renal proximal tubules. Eur. J. Pharmacol. 288: 139-147.
181. Grandy, D. K., Zhang, Y. A., Bouvier, C., Zhou, Q. Y., Johnson, R. A., Allen, L., Buck, K., Bunzow, J. R., Salon, J. and Civelli, O. (1991) Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc. Natl. Acad. Sci. USA 88: 9175-9179.
182. 1 cells. Am. J. Physiol. 268: F423-F434.
183. Gros, R., Benovic, J. L., Tan, C. M. and Feldman, R. D. (1997) G-protein-coupled receptor kinase activity is increased in hypertension. J. Clin. Invest. 99: 2087-2093.
184. Grossman, E., Hoffman, A., Tamrat, M., Armando, I., Keiser, H. R. and Goldstein, D. S. (1991) Endogenous dopa and dopamine responses to dietary salt loading in salt-sensitive rats. J. Hypertens. 9: 259-263.
185. + ATPase by G proteins in spontaneously hypertensive rats. Am. J. Physiol. 267: F1069-F1075.
186. Häberle, D. A., Konigbauer, B., Kawabata, M. and Ushiogi, Y. (1991) Renal blood flow control by tubuloglomerular feedback (TGF) in normal and spontaneously hypertensive rats - a role for dopamine and adenosine. Klin. Wochenschr. 69: 587-596.
187. Hafdi, Z., Couette, S., Comoy, E., Prie, D., Amiel, C. and Friedlander, G. (1996) Locally formed 5-hydroxytryptamine stimulates phosphate transport in cultured opossum kidney cells and in rat kidney. Biochem. J. 320: 615-621.
188. Hagege, J. and Richet, G. (1985) Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int. 27: 3-8.
189. Hagiwara, N., Kubota, T., Kubokawa, M. and Fujimoto, M. (1990) Effects of dopamine on the transport of Na, H, and Ca in the bullfrog proximal tubule. Jpn. J. Physiol. 40: 351-368.
190. Hahn, R. A. and Wardell, J. R., Jr. (1980) Renal vascular activity of SK&.F 38393 and dopamine in anesthetized dogs. J. Cardiovasc. Pharmacol. 2: 583-593.
191. Halpin, P. A. and Renfro, J. L. (1996) Renal organic anion secretion: evidence for dopaminergic and adrenergic regulation. Am. J. Physiol. 271: R1372-R1379.
192. Hansell, P. (1995) In vivo evidence for a defect in the dopamine DA1 receptor in the prehypertensive Dahl salt-sensitive rat. Exp. Nephrol. 3: 15-22.
193. Hansell, P. and Fasching, A. (1991) The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int. 39: 253-258.
194. Harris, R. C., Becker, B. N. and Cheng, H.-F. (1997) Acute and chronic mechanisms for regulating proximal tubule angiotensin II receptor expression. J. Am. Soc. Nephrol. 8: 306-313.
195. Harvey, J. N., Worth, D. P., Brown, J. and Lee, M. R. (1986) Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension. Br. J. Clin. Pharmacol. 21: 53-61.
196. Hayashi, M., Yasuyoshi, Y., Kitajima, W. and Saruta, T. (1990) Aromatic L-amino acid decarboxylase activity along the rat nephron. Am. J. Physiol. 258: F28-F33.
197. Hayashi, M., Yamaji, Y., Kitajima, W. and Saruta, T. (1991) Effects of high salt intake on dopamine production in rat kidney. Am. J. Physiol. 260: E675-E679.
198. Hegde, S. S. and Lokhandwala, M. F. (1988) Involvement of cyclic-AMP in the hypotensive response to fenoldopam but not to quinpirole in the anesthetized rat. J. Auton. Pharmacol. 2: 63-68.
199. Hegde, S. S. and Lokhandwala, M. F. (1992) Stimulation of renal dopamine production during acute volume expansion requires the presence of intact vagi but not renal nerves. Clin. Exp. Hypertens. [A] 14: 1169-1187.
200. Hegde, S. S., Jadhav, A. L. and Lokhandwala, M. F. (1989a) Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 13: 828-834.
201. Hegde, S. S., Ricci, A., Amenta, F. and Lokhandwala, M. F. (1989b) Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. J. Pharmacol. Exp. Ther. 251: 1237-1245.
202. Henrich, W. L. and Levi, M. (1991) Ontogeny of renal renin release in spontaneously hypertensive rat and Wistar-Kyoto rat. Am. J. Physiol. 260: F530-F535.
203. Hess, E. J. and Creese, I. (1987) Biochemical characterization of dopamine receptors. In: Dopamine Receptors, pp. 1-27, Creese, I. and Fraser, C. M. (eds.) Alan R. Liss, Inc., New York.
204. Heyman, S. N., Kaminski, N. and Brezis, M. (1995) Dopamine increases renal medullary blood flow without improving regional hypoxia. Exp. Nephrol. 3: 331-337.
205. Ho, C. S., Ho, S. C. and Swaminathan, R. (1993) Dietary electrolytes and urinary natriuretic factors. Int. J. Cardiol. 39: 1-4.
206. Ho, C. S., Butt, A., Semra, Y. K. and Swaminathan, R. (1997) Effect of carbidopa on excretion of sodium, dopamine, and ouabain-like substance in the rat. Hypertension 30: 1544-1548.
207. Hoffman, J. (1997) The potential for isoenzyme selective modulation of protein kinase C. FASEB J. 11: 649-669.
208. + antiporter. Acta Physiol. Scand. 148: 55-61.
209. Horiuchi, A., Albrecht, F., Eisner, G. M., Jose, P. A. and Felder, R. A. (1992) Renal dopamine receptors and pré- and post-cAMP mediated sodium transport defect in the spontaneously hypertensive rat. Am. J. Physiol. 263: F1105-F1111.
210. + ATPase activity through protein kinase A. Mol. Pharmacol. 43: 281-285.
211. 2 dopamine receptors in the dog renal vasculature. Eur. J. Pharmacol. 197: 125-130.
212. Houillier, P., Chambray, R., Achaard, J. M., Froissart, M., Poggioli, J. and Paillard, M. (1996) Signaling pathways in the biphasic effect of angiotensin II on apical Na/H antiport activity in proximal tubule. Kidney Int. 50: 1496-1505.
213. Hughes, J. M., Beck, T. R., Rose, C. E., Jr. and Carey, R. M. (1986) Selective dopamine-1 receptor stimulation produces natriuresis by a direct tubular action. J. Hypertens. 4: S106-S108.
214. 3H] Sch 23390. Am. J. Physiol. 257: F414-F423.
215. 2 production in IMCD cells. I. Stimulation by dopamine. Am. J. Physiol. 261: F647-F654.
216. 2K) in the kidney inner medulla. Proc. Natl. Acad. Sci. USA 88: 3170-3174.
217. +,K(+)-ATPase in kidney of spontaneously hypertensive rats. Clin. Exp. Hypertens. 18: 963-974.
218. q/11 proteins in spontaneously hypertensive rats. Am. J. Physiol. 272: F339-F346.
219. +-ATPase in renal proximal tubules via cAMP pathway. Eur. J. Pharmacol. 321: 259-263.
220. +-ATPase activity by dopamine and an α-adrenergic agonist. Proc. Natl. Acad. Sci. USA 90: 21-24.
221. Ibarra, F. R., Aguirre, J., Nowicki, S., Barontini, M., Arrizurieta, E. E. and Armando, I. (1996) Demethylation of 3-O-methyldopa in the kidney: a possible source for dopamine in the urine. Am. J. Physiol. 270: F862-F868.
222. Imondi, A. R., Hagerman, L. M. and Belair, E. J. (1979) Inhibition of saline-induced diuresis in the rat by sulpiride. Experientia 35: 251-252.
223. Isaac, J., Berndt, T. J., Chinnow, S. L., Tyce, G. M., Dousa, T. P. and Knox, F. G. (1992) Dopamine enhances the phosphaturic response to parathyroid hormone in phosphate-deprived rats. J. Am. Soc. Nephrol. 2: 1423-1429.
224. Ishizaka, N., Alexander, R. W., Laursen, J. B., Kai, H., Fukui, T., Oppermann, M., Lefkowitz, R. J., Lyons, P. R. and Griendling, K. K. (1997) G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta. J. Biol. Chem. 272: 32482-32488.
225. Jaber, M., Robinson, S. W., Missale, C. and Caron, M. G. (1996) Dopamine receptors and brain function. Neuropharmacology 35: 1503-1519.
226. + antiport activity in rat renal cortical brush border membrane vesicles. Clin. Exp. Hypertens. A14: 653-666.
227. Jadhav, A. L. and Lokhandwala, M. F. (1990) Dietary sodium-induced changes in renal noradrenergic and dopaminergic responses in rats. J. Hum. Hypertens. 4: 163-164.
228. Jadhav, A. L., Ricci, A., Amenta, F. and Lokhandwala, M. F. (1991) Renal dopamine and changes in dopamine receptor ligand binding during high sodium intake. Clin. Exp. Hypertens. [A] 13: 1371-1381.
229. Jeffrey, R. F., MacDonald, T. M., Marwick, K. and Lee, M. R. (1988) The effect of carbidopa and indomethacin on the renal response to 7-L-glutamyl-L-dopa in normal man. Br. J. Clin. Pharmacol. 25: 195-201.
230. Jensen, B. L., Ellekvist, P. and Skott, O. (1997) Chloride is essential for contraction of acid release in Chinese hamster ovary cells. Mol. Pharmacol. 39: 364-369.
231. Jespersen, B., Randlov, A., Abrahamsen, J., Fogh-Andersen, N. and Kanstrup, I.-L. (1997) Effects of PTH (1-34) on blood pressure, renal function, and hormones in essential hypertension. Am. J. Hypertens. 10: 1356-1367.
232. 3H]SCH23390 binding. Methods Find. Exp. Clin. Pharmacol. 17: 455-461.
233. Jose, P. A. and Felder, R. A. (1996) What we can learn from the selective manipulation of dopaminergic receptors about pathogenesis and treatment of hypertension? Curr. Opin. Nephrol. Hypertens. 5: 447-451.
234. Jose, P. A., Felder, R. A., Holloway, R. R. and Eisner, G. M. (1986) Dopamine receptors modulate sodium excretion in denervated kidney. Am. J. Physiol. 250: F1033-F1038.
235. Jose, P. A., Eisner, G. M. and Robillard, J. E. (1987) Renal hemodynamics and natriuresis induced by the dopamine-1 agonist, SKF 82526. Am. J. Med. Sci. 30: 181-186.
236. Jose, P. A., Holloway, R. R., Campbell, T. W. and Eisner, G. M. (1988) Dopamine blockade attenuates the natriuresis of saline loading in the adrenalectomized rat. Nephron 48: 54-57.
237. + exchange activity in proximal tubular brush border membrane vesicles (PTBBMV) in spontaneously hypertensive rats. J. Am. Soc. Nephrol. 2: 479.
238. Jose, P. A., Raymond, J. R., Bates, M. D., Aperia, A., Felder, R. A. and Carey, R. M. (1992) The renal dopamine receptors. J. Am. Soc. Nephrol. 2: 1265-1278.
239. Jose, P. A., Eisner, G. M., Drago, J., Carey, R. M. and Felder, R. A. (1996) Dopamine receptor signaling defects in spontaneous hypertension. Am. J. Hypertens. 9: 400-405.
240. Jose, P. A., Asico, L. D., Eisner, G. M., Pocchiari, F., Semeraro, C., Carey, R. M. and Felder, R. A. (1997) Z1046, a novel dopaminergic agonist: vasodilator and natriuretic and inhibitory of renin secretion. J. Invest. Med. 45: 277A.
241. Jose, P. A., Eisner, G. M. and Felder, R. A. (1998) Dopaminergic mechanisms in the development of hypertension. In: Development of the Hypertensive Phenotype: Basic and Clinical Studies, Blizard, D., Chevalier, R. and McCarty, R. (eds.) Elsevier Science, Amsterdam Publishing Division, Amsterdam, in press.
242. Kaneda, Y. and Bello-Reuss, E. (1983) Effect of dopamine on phosphate reabsorption in isolated perfused rabbit proximal tubules. Miner. Electrolyte Metab. 9: 147-150.
243. Kaneko, S., Eisner, G. M. and Jose, P. A. (1990) Effect of pramipexole, a dopamine-1/dopamine-2 receptor agonist, on sodium excretion and blood pressure in spontaneously hypertensive rats. J. Auton. Pharmacol. 10 (Suppl. 1): s53-s60.
244. Kansra, K., Chen, C. and Lokhandwala, M. F. (1995) Dopamine causes stimulation of protein kinase C in rat renal proximal tubules by activating dopamine D1 receptors. Eur. J. Pharmacol. 289: 391-394.
245. Kanterman, R. Y., Mahan, L. C., Briley, E. M., Monsma, F. J., Jr., Sibley, D. R., Axelrod, J. and Felder, C. C. (1991) Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol. Pharmacol. 39: 364-369.
246. Kapusta, D. R. and Robie, N. W. (1988) Plasma dopamine regulation of canine renal blood flow. Am. J. Physiol. 255: R379-R387.
247. Karim, Z., Defontaine, N., Paillard, M. and Poggioli, J. (1995) Protein kinase C isoforms in rat kidney proximal tubule. Acute effect of angiotensin II. Am. J. Physiol. 269: C134-C140.
248. 22Na recovery by the micro injection method. J. Hypertens. 4 (Suppl. 3): S255-S256.
249. Kebabian, J. W. and Calne, D. B. (1979) Multiple receptors for dopamine. Nature 277: 93-96.
250. Kikuchi, K., Miyama, A., Nakao, T., Takigami, Y., Kondo, A., Mito, T., Ura, N., Tsuzuki, M. and Iimura, O. (1982) Hemodynamic and natriuretic response to intravenous infusion of dopamine in patients with essential hypertension. Jpn. Circ. J. 46: 486-493.
251. Kinoshita, S., Sidhu, A. and Felder, R. A. (1989) Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J. Clin. Invest. 84: 1849-1856.
252. Kinoshita, S., Ohlstein, E. H. and Felder, R. A. (1990) Dopamine-1 receptors in rat proximal convoluted tubule: regulation by intrarenal dopamine. Am. J. Physiol. 258: F1068-F1074.
253. 3 preferring compounds in discrete areas of the rat brain. J. Neural Transm. 102: 209-220.
254. Koyama, S., Sasaki, M., Setoyama, T., Takahashi, K., Togashi, K., Suzuki, K., Kakki, N. and Imai, M. (1985) Dopaminergic modulation of the renal effect of arginine-vasopressin in water-loaded rats. Jpn. J. Pharmacol. 38: 25-30.
255. Krishna, G. G., Danovitch, G. M., Beck, F. W. and Sowers, J. R. (1985) Dopaminergic mediation of the natriuretic response to volume expansion. J. Lab. Clin. Med. 105: 214-218.
256. Kuchel, O. (1995) Genetic determinants of dopaminergic activity: potential role in blood pressure regulation. Hypertens. Res. 18 (Suppl. 1): S1-S10.
257. Kuchel, O. G. and Kuchel, G. A. (1991) Peripheral dopamine in pathophysiology of hypertension: interaction with aging and lifestyle. Hypertension 18: 709-721.
258. Kuchel, O., Buu, T., Hamet, P., Larocehelle, P., Bourque, M. and Genest, J. (1982) Dopamine surges in hyperadrenergic essential hypertension. Hypertension 4: 842-852.
259. 4 receptor-selective ligand. Eur. J. Pharmacol. 331: 333-336.
260. 4 receptor. J. Med. Chem. 39: 1941-1942.
261. Kurtz, A., Della Bruna, R., Pratz, J. and Cavero, I. (1988) Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release. J. Cardiovasc. Pharmacol. 12: 658-663.
262. Lahti, R. A., Mutin, A., Cochrane, E. V., Tepper, P. G., Dijkstra, D., Wikstrom, H. and Tamminga, C. A. (1996) Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptors. Eur. J. Pharmacol. 301: R11-R13.
263. Lamers, A. E., Groneveld, D., de Kleijn, D. P., Geeraedts, F. C., Leunissen, J. A., Flik, G., Wendelaar Bonga, S. E. and Martens, G. J. (1996) Cloning and sequence analysis of a hypothalamic cDNA encoding a Die dopamine receptor in tilapia. Biochim. Biophys. Acta 1308: 17-22.
264. Lang, W. J. and Woodman, O. L. (1982) Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog. Br. J. Pharmacol. 77: 23-28.
265. Lappe, R. W., Todt, J. A. and Wendt, R. L. (1986) Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 236: 187-191.
266. Laradi, A., Sakhrani, L. M. and Massry, S. G. (1986) Effect of dopamine on sodium uptake by renal proximal tubule cells of rabbit. Miner. Electrolyte Metab. 12: 303-307.
267. Lee, M. R. (1982) Dopamine and the kidney. Clin. Sci. 62: 439-448.
268. Lee, M. R. (1987) Dopamine, the kidney and essential hypertension. Studies with gludopa. Clin. Exp. Hypertens. 9: 977-986.
269. 1A dopamine receptor gene in brain and kidney. DNA Cell Biol. 16: 1267-1275.
270. Lefkowitz, R. J., Cotecchia, S., Kjelsberg, M. A., Pitcher, J., Koch, W. J., Inglese, J. and Caron, M. G. (1993) Adrenergic receptors: recent insights into their mechanism of activation and desensitization. Adv. Second Messenger Phosphorylation Res. 28: 1-9.
271. Lenz, T. and Wagner, G. (1995) Antihypertensive care with calcium antagonists. In: Hypertension. Pathophysiology, Diagnosis and Management, pp. 2953-2968, Laragh, J. H. and Brenner, B. M. (eds.) Raven Press, New York.
272. +-ATPase. Am. J. Physiol. 269: F673-F680.
273. 1-adrenergic activation of Na-K-ZCl cotransport. Am. J. Physiol. 273: C1632-C1640.
274. 1-adrenergic stimulation in human airway epithelial cells. Am. J. Physiol. 273: C937-C943.
275. Lifton, R.P. (1996) Molecular genetics of human blood pressure variation. Science 272: 676-680.
276. Liu, L. X., Monsma, F. J., Jr., Sibley, D. R. and Chiodo, L. A. (1996) D2L, D2S, and D3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms. Synpase 24; 156-164.
277. Liu, Y. F., Civelli, O., Zhou, Q. Y. and Albert, P. R. (1992) Cholera toxin-sensitive 3′,5′-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. Mol. Endocrinol. 6: 1815-1824.
278. +-ATPase affects its conformational equilibrium. Proc. Natl. Acad. Sci. USA 93: 132-137.
279. Lohse, M. J., Krasel, C., Winstel, R. and Mayor, F., Jr. (1996) G-protein-coupled receptor kinases. Kidney Int. 49: 1047-1052.
280. Lokhandwala, M. F. and Steenberg, M. L. (1984) Selective activation by LY141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine. J. Pharmacol. Exp. Ther. 228: 161-167.
281. Lokhandwala, M. F., Tadepalli, A. S. and Jandhyala, B. S. (1979) Cardiovascular actions of bromocriptine: evidence for a neurogenic mechanism. J. Pharmacol. Exp. Ther. 211: 620-625.
282. +)-Sulpiride antagonizes the renal effects of gamma-L-glutamyl-L-dopa in man. Br. J. Clin. Pharmacol. 25: 203-212.
283. 3 receptor expressed in transfected cell lines. Eur. J. Pharmacol. 266: 79-85.
284. Maeda, Y., Terada, Y., Nonoguchi, H. and Knepper, M. A. (1992) Hormone and autocoid regulation of cAMP production in rat IMCD subsegments. Am. J. Physiol. 263: F319-F327.
285. 2+ mobilization in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87: 2196-2200.
286. Manoogian, C., Nadler, J., Ehrich, L. and Horton, R. (1988) The renal vasodilating effect of dopamine is mediated by calcium flux and prostacyclin release in man. J. Clin. Endocrinol. Metab. 66: 678-683.
287. Marcou, M., Munday, K. A., Horn, N. and Woodruff, G. N. (1982) A study of dopamine receptors in guinea-pig renal tissue. Arch. Int. Pharmacodyn. Ther. 259: 59-71.
288. 1A receptors in the rat small intestine. J. Surg. Res. 54: 616-620.
289. Massry, S. G. and Kleeman, C. R. (1972) Calcium and magnesium excretion during acute rise in glomerular filtration rate. J. Lab. Clin. Med. 80: 654-664.
290. Matsumoto, M., Hidaka, K., Tada, S., Tasaki, Y. and Yamaguchi, T. (1995) Full-length cDNA cloning and distribution of human D4 receptor. Mol. Brain Res. 29: 157-162.
291. McClanahan, M., Sowers, J. R., Beck, F. W., Mohanty, P. K. and McKenzie, T. (1985) Dopaminergic regulation of natriuretic response to acute volume expansion in dogs. Clin. Sci. 68: 263-269.
292. McDonald, R. H., Goldberg, L. I., McNay, J. L. and Tuttle, E. P., Jr. (1964) Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J. Clin. Invest. 43: 1116-1124.
293. McGrath, B., Bode, K., Luxford, A., Howden, B. and Jablonski, P. (1985) Effects of dopamine on renal function in the rat isolated perfused kidney. Clin. Exp. Pharmacol. Ther. 12: 343-352.
294. + conductance in the guinea-pig substantia nigra. Neurosci. Lett. 224: 211-255.
295. McKee, M., Scavone, C. and Nathanson, J. A. (1994) Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc. Natl. Acad. Sci. USA 91: 12056-12060.
296. Mei, Y. A., Griffon, N., Buquet, C., Martres, M. P., Vaudry, H., Schwartz, J. C., Sokoloff, P. and Cazin, L. (1996) Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule. Neuroscience 68: 107-116.
297. +ATPase in renal tubule cells. Proc. Natl. Acad. Sci. USA 86: 8068-8072.
298. Meister, B., Bean, A. J. and Aperia, A. (1993) Catechol-O-methyl transferase in the kidney and its appearance during ontogeny. Kidney Int. 44: 726-733.
299. Mendez, R. E., Lopez, R., Lopez, G., Marti, M. S. and Martinez-Maldonado, M. (1991) Effects of dopamine-receptor antagonists and renal denervation on amino acid-induced hyperfiltration. Am. J. Physiol. 261: F70-F75.
300. Mezey, E., Eisenhofer, G., Harta, G., Hansson, S., Gould, L., Hunyady, B. and Hoffman, B. J. (1996) A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc. Natl. Acad. Sci. USA 93: 10377-10382.
301. 2-, β-adrenergic receptors and their signaling. Hypertension 22: 169-177.
302. Michel, M. C., Farke, W., Erdbrügger, W., Philipp, T. and Brodde, O.-E. (1994) Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats. Hypertension 23: 653-658.
303. Middleton, J. P., Khan, W. A., Collinsworth, G., Hannun, Y. A. and Medford, R. M. (1993) Heterogeneity of protein kinase C-mediated rapid regulation of Na/K-ATPase in kidney epithelial cells. J. Biol. Chem. 268: 15958-15964.
304. Minuz, P., Coruzzi, P., Paluani, F., Ravanetti, C., Lechi, C., Delva, P., Lechi, A. and Novarini, A. (1989) Increased urinary 6-keto-PGF1 alpha excretion during water immersion is blunted by metoclopramide in normal man. J. Endocrinol. Invest. 12: 597-600.
305. Missale, C., Castelletti, L., Memo, M., Carruba, M. O. and Spano, P. F. (1988) Identification and characterization of postsynaptic Dl- and D2-dopamine receptors in the cardiovascular system. J. Cardiovasc. Pharmacol. 11: 643-650.
306. 2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-929.
307. Monsma, F. J., Jr., Mahan, L. C., McVittie, L. D., Gerfen, C. R. and Sibley, D. R. (1990) Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA 87: 6723-6727.
308. Morgunov, N. and Baines, A. D. (1981) Renal nerves and catecholamine excretion. Am. J. Physiol. 240: F75-F81.
309. Morgunov, N. and Baines, A. D. (1985) Vagal afferent activity and renal nerve release of dopamine. Can. J. Physiol. Pharmacol. 63: 636-641.
310. Mühlbauer, B. and Osswald, H. (1993) Urinary dopamine excretion in conscious rats: effects of carbidopa in different states of sodium balance. Renal Physiol. Biochem. 16: 117-124.
311. Mühlbauer, B. and Osswald, H. (1994) Feeding-induced increase in urinary dopamine excretion is independent of renal innervation and sodium intake. Am. J. Physiol. 266: F563-F567.
312. Mühlbauer, B., Hartenburg, E. and Osswald, H. (1994) Renal response to amino acid infusion in rats: effect of dopamine receptor antagonists and benserazide. Naunyn Schmiedebergs Arch. Pharmacol. 349: 244-249.
313. Mühlbauer, B., Mickeler, C. and Schenk, F. (1997a) Proteininduced increase in urinary dopamine in normal and diabetic rats: role of catecholamine precursors. Am. J. Physiol. 273: R80-R85.
314. Mühlbauer, B., Spöhr, F., Schmidt, R. and Osswald, H. (1997b) Role of renal nerves and endogenous dopamine in amino acidinduced glomerular hyperfiltration. Am. J. Physiol. 273: F144-F149.
315. Murthy, V. V., Gilbert, J. C., Goldberg, L. I. and Kuo, J. F. (1976) Dopamine-sensitive adenylate cyclase in canine renal artery. J. Pharmacol. Exp. Ther. 28: 567-571.
316. Muto, S., Tabei, K., Asano, Y. and Imai, M. (1985) Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule. Eur. J. Pharmacol. 114: 393-397.
317. 3H-haloperidol of the dopamine receptor in the rat kidney particulate preparation. Jpn. J. Pharmacol. 30: 891-898.
318. Nakajima, T., Naitoh, F. and Kuruma, I. (1977) Dopamine-sensitive adenylate cyclase in the rat kidney particulate preparation. Eur. J. Pharmacol. 41: 163-169.
319. Nash, S. R., Godinot, N. and Caron, M. G. (1993) Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Mol. Pharmacol. 44: 918-925.
320. Neiberger, R. E. and Passmore, J. C. (1979) Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage. Kidney Int. 15: 219-226.
321. Neuser, D., Schulte-Brinkmann, R., Knorr, A. and Kazda, S. (1990) Long-term hypotensive effect of parathyroid hormone in stroke prone spontaneously hypertensive rats. Eur. J. Pharmacol. 182: 569-571.
322. + exchange assessed by quantification of extracellular acidification. J. Biol. Chem. 267: 25748-25753.
323. Nielsen, C. B. and Pedersen, E. B. (1997) Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods. Clin. Nephrol. 47: 304-309.
324. + dependence, effect of cell environment and protein kinases. Acta Physiol. Scand. 49: 377-384.
325. +-ATPase in Dahl saltsensitive rat. Am. J. Physiol. 264: F448-F452.
326. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21: 767-771.
327. 1-receptors. Biochemistry 28: 6925-6930.
328. + antiport activity in the rabbit renal proximal tubule. J. Clin. Invest. 80: 1755-1762.
329. +-ATPase. J. Clin. Invest. 99: 1224-1230.
330. Oates, N. S., Ball, S. G., Perkins, C. M. and Lee, M. R. (1979) Plasma and urine dopamine in man given sodium chloride in the diet. Clin. Sci. 56: 261-264.
331. 1A receptor protein in rat kidneys. Am. J. Physiol. 268: F1185-F1197.
332. O'Connell, D. P., Ragsdale, N. V., Boyd, D. G., Felder, R. A. and Carey, R. M. (1997) Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 29: 115-122.
333. O'Connell, D. P., Aherne, A. M., Lane, E., Felder, R. A. and Carey, R. M. (1998a) Detection of dopamine receptor D1A subtype specific mRNA in rat kidney by in situ amplification. Am. J. Physiol. 274: F232-F241.
334. 3 receptor protein in the rat kidney. Hypertension, in press.
335. Ohbu, K. and Felder, R. A. (1991) DA1 dopamine receptors in renal cortical collecting duct. Am. J. Physiol. 261: F890-F895.
336. Ohbu, K. and Felder, R.A. (1993) Nephron segment specificity of dopamine
337. Ohbu, K., Hendley, E. D., Yamaguchi, I. and Felder, R. A. (1993) Renal dopamine-1 receptors in hypertensive inbred rat strains with and without hyperactivity. Hypertension 21: 485-490.
338. Ohbu, K., Kaskel, F. J., Kinoshita, S. and Felder, R. A. (1995) Dopamine-1 receptors in the proximal convoluted tubule of the Dahl rat: defective coupling to adenylate cyclase. Am. J. Physiol. 268: R231-R235.
339. Olsen, N. V., Hansen, J. M., Ladefoged, S. D., Fogh-Andersen, N. and Leyssac, P. P. (1990) Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. Clin. Sci. 78: 503-507.
340. O'Malley, K. L., Harmon, S., Tang, L., Han, S. and Todd, R. D. (1992) The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 4: 137-146.
341. Ominato, M., Satoh, T. and Katz, A. I. (1996) Regulation of NaK-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J. Memb. Biol. 152: 235-243.
342. Onsgard-Meyer, M. J., Berndt, T. J., Khraibi, A. A. and Knox, F. G. (1994) Phosphaturic effect of parathyroid hormone in the spontaneously hypertensive rat. Am. J. Physiol. 267: R78-R83.
343. Ozono, R., O'Connell, D. P., Vaughan, C., Botkin, S. J., Walk, S. F., Felder, R. A. and Carey, R. M. (1996) Expression of the subtype 1A dopamine receptor in the rat heart. Hypertension 27: 693-703.
344. 1 receptor protein in the human heart and kidney. Hypertension 30: 725-729.
345. 125I]L-750,667, a novel radioligand for the dopamine D4 recep-tor. Mol. Pharmacol. 50: 1658-1664.
346. + pump in OK cells. Mol. Pharmacol. 52: 88-97.
347. Pedemonte, C. H., Pressley, T. A., Lokhandwala, M. F. and Cinelli, A. R. (1997b) Regulation of Na,K-ATPase transport activity by protein kinase C. J. Memb. Biol. 155: 219-227.
348. Pelayo, J. C., Fildes, R. D., Eisner, G. M. and Jose, P. A. (1983) Effects of dopamine blockade on renal sodium excretion. Am. J. Physiol. 245: F247-F253.
349. Pendleton, R. G., Samler, L., Kaiser, C. and Ridley, P. T. (1978) Studies on renal dopamine receptors with a new agonist. Eur. J. Pharmacol. 51: 19-28.
350. Perrichot, R., Garcia-Ocana, A., Couette, S., Como, E., Amiel, C. and Friedlander, G. (1995) Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors. Biochem. J. 312: 433-437.
351. Petrovic, T. and Bell, C. (1986) Catecholamines in kidneys of normotensive and genetically hypertensive rats. Effects of salt load. Hypertension 8: 122-127.
352. Piercey, M. F., Hoffmann, W. E., Smith, M. W. and Hyslop, D. K. (1996a) Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists. Eur. J. Pharmacol. 312: 35-44.
353. Piercey, M. F., Moon, M. W., Sethy, V. H., Schreur, P. J., Smith, M. W., Tang, A. H. and Von Voigtlander, P. F. (1996b) Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype. Eur. J. Pharmacol. 317: 29-38.
354. Pinto-do-O, P. C., Chivalin, A. V., Katz, A. I., Soares-da-Silva, P. and Bertorello, A. M. (1997) Short-term vs. sustained inhibition of proximal tubule Na,K-ATPase activity by dopamine: cellular mechanisms. Clin. Exp. Hyertens. 19: 73-86.
355. 2 receptor synergism. Nature 53: 164-167.
356. Poggioli, J., Karim, Z., Defontaine, N., Lazar, G., Bodi, I. and Paillard, M. (1995) Protein kinase C (PKC) isozymes present in brush border membrane vesicles (BBMV) isolated from rat kidney proximal tubules (PT) are activated by angiotensin II (All). J. Am. Soc. Nephrol. 6: 743.
357. Pugsley, T. A., Davis, M. D., Akunne, H. C., Mackenzie, R. G., Shih, Y. H., Damsma, G., Wikstrom, H., Whetzel, S. Z., Georgie, L. M., Cooke, L. W., Demattos, S. B., Corbin, A. E., Glase, S. A., Wise, L. D., Dijkstra, D. and Heffner, T. (1995) Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275: 1355-1366.
358. Pupilli, C., Lanzilotti, R., Fiorelli, G., Selli, C., Gomez, R. A., Carey, R. M., Serio, M. and Manelli, M. (1994) Dopamine D2 receptor gene expression and binding sites in adrenal medulla and pheochromocytoma. J. Clin. Endocrinol. Metab. 79: 56-61.
359. Racz, K., Kuchel, O., Buu, N. T. and Tenneson, S. (1986) Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ. Res. 57: 889-897.
360. Ragsdale, N. V., Lynd, M., Chevalier, R. L., Felder, R. A., Peach, M. J. and Carey, R. M. (1990) Selective peripheral dopamine-1 receptor stimulation: differential responses to sodium loading and depletion in humans. Hypertension 15: 914-921.
361. +)-pump activity by dopamine in rat tail arteries. Eur. J. Pharmacol. 284: 289-297.
362. +, K(+)-ATPase activity by dopamine in cultured rat aortic smooth muscle cells. Eur. J. Pharmacol. 305: 223-230.
363. Reale, V., Hannan, F., Hall, L. M. and Evans, P. (1997) Agonistspecific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J. Neurosci. 17: 6545-6553.
364. Reiner, N. E. and Thompson, W. L. (1979) Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs. J. Infect. Dis. 140: 564-575.
365. 1 receptors in the human kidney. J. Pharmacol. Exp. Ther. 264: 431-437.
366. 3 receptor in peripheral mononuclear cells of essential hypertensives. Hypertension 30: 1566-1571.
367. 3 receptor. Mol. Pharmacol. 52: 508-514.
368. Romero-Vecchione, E., Vasquez, J., Lema, G., Guerrero, H., Rosa, F. and Bermudez, M. (1995) Low urinary dopamine excretion associated to low sodium excretion in normotensive Piaroa Amazonian ethnia compared to urban subjects. Invest. Clin. 36: 61-71.
369. Roth, B. L., Tandra, S., Burgess, L. H., Sibley, D. R. and Meltzer, H. Y. (1995) D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120: 365-368.
370. Rump, L. C., Wilde, K., Bohmann, C. and Schollmeyer, P. (1992) Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney. Naunyn Schmiedebergs Arch. Pharmacol. 345: 300-308.
371. Rump, L. C., Schwertfeger, E., Schuster, M. J., Schaible, U., Frankenschmidt, A. and Schollmeyer, P. J. (1993) Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices. Kidney Int. 43: 197-204.
372. Saito, I., Takeshita, E., Saruta, T., Nagano, S. and Sekihara, T. (1986) Urinary dopamine excretion in normotensive subjects with and without family history of hypertension. J. Hypertens. 4: 57-60.
373. Saito, I., Itsuji, S., Takeshita, E., Kawabe, H., Nishino, M., Winai, H., Hasegawa, C., Saruta, T., Nagano, S. and Sekihara, T. (1994) Increased urinary dopamine excretion in young patients with essential hypertension. Clin. Exp. Hypertens. 6: 29-39.
374. Sanada, H., Jose, P. A., Yu, P.-Y., Hazen-Martin, D., Carey, R. M., Bruns, D. and Felder, R. A. (1997a) Human hypertensives have a renal proximal tubular defect in dopamine-1 receptor/adenylyl cyclase coupling. J. Am. Soc. Nephrol. 8: 307A.
375. 3 receptors in rat juxtaglomerular cells. Clin. Exp. Hypertens. 19: 93-105.
376. 2. J. Clin. Invest. 89: 1496-1500.
377. Satoh, T., Cohen, H. T. and Katz, A. I. (1993a) Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids. J. Clin. Invest. 91: 409-415.
378. Satoh, T., Cohen, H. T. and Katz, A. I. (1993b) Different mechanisms of renal Na-K-ATPase regulation by protein kinases in proximal and distal nephron. Am. J. Physiol. 265: F399-F405.
379. 3 receptor antagonist, activates locomotion in rodents. J. Pharmacol. Exp. Ther. 275: 1239-1246.
380. Schelling, J. R., Singh, H., Marzec, R. and Linas, S. L. (1994) Angiotensin II-dependent proximal tubule sodium transport is mediated by cAMP modulation of phospholipase C. Am. J. Physiol. 267: C1239-C1245.
381. Schiffmann, S. N., Lledo, P. M. and Vincent, J. D. (1995) Dopamine D1 receptor modulates the voltage-gated sodium current in rat striatal neurones. J. Physiol. 483: 95-107.
382. Schlachter, S. K., Poel, T. J., Lawson, C. F., Dinh, D. M., Lajiness, M. E., Romero, A. G., Rees, S. A., Duncan, J. N. and Smith, M. W. (1997) Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor. Eur. J. Pharmacol. 322: 283-286.
383. + channel activity in A6 renal cells. FASEB J. 12: 5684.
384. Schmidt, M. and Imbs, J.-L. (1979) Effets rénaux de la bromocriptine. J. Pharmacol. 10: 525-632.
385. Scholz, H. (1997) Pharmacological aspects of calcium channel blockers. Cardiovasc. Drugs Ther. 10 (Suppl. 3): 869-872.
386. Schoors, D. F. and Dupont, A. G. (1991) Increased dopamine-induced nephrogenous cAMP formation in hypertension. Am. J. Hypertens. 4: 494-499.
387. Schwartz, T. W. (1996) Molecular structure of G-protein-coupled receptors. In: Textbook of Receptor Pharmacology, pp. 65-84, Foreman, J. C. and Johansen, T. (eds.) CRC Press, Boca Raton.
388. 1 pituitary cells. FEBS Lett. 312: 123-126.
389. Seabrook, G. R., Kemp, J. A., Freedman, S. B., Patel, S., Sinclair, H. A. and McAllister, G. (1994) Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br. J. Pharmacol. 111: 391-393.
390. Sealy, J. E., Blumfeld, J. D., Bell, G. M., Pecker, M. S., Sommers, S. C. and Laragh, J. H. (1996) Nephron heterogeneity with unsuppressible renin secretion: a cause of essential hypertension. In: Hypertension. Pathophysiology, Diagnosis, and Management, 2nd edn., pp. 1405-1421, Laragh, J. H. and Brenner, B. M. (eds.) Raven Press, New York.
391. Seeman, P. (1993) Receptor Tables. Vol. 2; Drug Dissociation Constants for Neuroreceptors and Transporters. SZ Research, Toronto.
392. Seeman, P. and Van Tol, H. H. M. (1994) Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15: 264-270.
393. A dopamine receptors: differential sensitivity of receptors to N-ethylmaleimide in normotensive and hypertensive rats. J. Hypertens. 14: 615-622.
394. 7 cells: involvement of protein kinase-C∈. Endocrinology 134: 783-789.
395. Seri, I. and Aperia, A. (1988) Contribution of dopamine 2 receptors to dopamine-induced increase in glomerular filtration rate. Am. J. Physiol. 254: F196-F201.
396. Seri, I., Eklof, A. C. and Aperia, A. (1987) Role of dopamine2-receptors in mediating renal vascular response to low dose dopamine infusion in the rat. Acta Physiol. Scand. 130: 563-569.
397. +-ATPase activity in rat renal cortical tubule cells. Am. J. Physiol. 255: F666-F673.
398. +)-ATPase. Am. J. Physiol. 258: F52-F60.
399. Shahedi, M., Laborde, K., Bussieres, L., Dechaux, M. and Sachs, C. (1992) Protein kinase C activation causes inhibition of Na/ K-ATPase activity in Madin-Darby canine kidney epithelial (MDCK) cells. Pflügers Arch. 420: 269-274.
400. Shahedi, M., Laborde, K., Azimi, S., Hamdani, S. and Sachs, C. (1995) Mechanisms of dopamine effects on Na-K-ATPase activity in Madin-Darby canine kidney (MDCK) epithelial cells. Pflügers Arch. 429: 832-840.
401. Sharif, N. A., Nunes, J. L., Lake, K. D., McClelland, D. L., Corkins, S. F., Lakatos, I., Rosenkranz, R. P., Whiting, R. L. and Eglen, R. M. (1995) Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studies. Gen. Pharmacol. 26: 727-735.
402. Sheikh-Hamad, D., Wang, Y.-P., Jo, O. D. and Yanagawa, N. (1993) Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am. J. Physiol. 264: F737-F743.
403. Shigetomi, S., Buu, N. T. and Kuchel, O. (1991) Dopaminergic abnormalities in borderline essential hypertensive patients. Hypertension 17: 997-1002.
404. Shulz, P. J., Sedor, J. R. and Abboud, H. E. (1987) Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am. J. Physiol. 253: H358-H364.
405. Sibley, D. R. and Monsma, F. J., Jr. (1992) Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13: 61-69.
406. Sidhu, A., Felder, R. A., Jose, P. A. and Fishman, P. H. (1990) Comparison of the central and renal dopamine-1 receptor. Am. J. Hypertens. 3: 37S-39S.
407. Sidhu, A., Vachvanichsanong, P., Jose, P. A. and Felder, R. A. (1992) Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats. J. Clin. Invest. 89: 789-793.
408. Siragy, H. M., Felder, R. A., Howell, N. L., Chevalier, R. L., Peach, M. J. and Carey, R. M. (1989) Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am. J. Physiol. 257: F469-F477.
409. Siragy, H. M., Felder, R. A., Howell, N. L., Chevalier, R. L., Peach, M. J. and Carey, R. M. (1990) Evidence that dopamine-2 mechanisms control renal function. Am. J. Physiol. 259: F793-F800
410. 2 dopamine receptor stimulation in the conscious dog. Am. J. Physiol. 262: F932-F938.
411. Slivka, S. R., Meier, K. E. and Insel, P. A. (1988) Alpha 1-adrenergic receptors promote phosphatidylcholine hydrolysis in MDCK-D1 cells. A mechanism for rapid activation of protein kinase C. J. Biol. Chem. 263: 12242-12246.
412. Slobodyansky, E., Aoki, Y., Gaznabi, A. K. M., Aviles, D. H., Fildes, R. D. and Jose, P. A. (1995) Dopamine and protein phosphatase activity in renal proximal tubules. Am. J. Physiol. 268: F279-F284.
413. Smit, A. J., Meijer, S., Wesseling, H., Donker, A. J. and Reitsma, W. D. (1988) Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease. Clin. Sci. 75: 421-428.
414. Smit, A. J., Meijer, S., Wesseling, H., Donker, A. J. and Reitsma, W. D. (1990) Dissociation of renal vasodilator and natriuretic effects of dopamine during sulpiride infusion in normal man. Eur. J. Clin. Pharmacol. 39: 221-226.
415. Soares-da-Silva, P. (1993a) Enhanced protein kinase C mediated inhibition of renal dopamine synthesis during high sodium intake. Biochem. Pharmacol. 45: 1791-1800.
416. 2-adrenoceptor agonists. Br. J. Pharmacol. 109: 569-576.
417. Soares-da-Silva, P. (1994) Source and handling of renal dopamine: its physiological importance. News Physiol. Sci. 9: 128-134.
418. Soares-da-Silva, P. and Fernandes, M. H. (1990) Regulation of dopamine synthesis in the rat kidney. J. Auton. Pharmacol. 10 (Suppl. 1): s25-s30.
419. Soares-da-Silva, P. and Fernandes, M. H. (1991) A study on the renal synthesis of dopamine in aged rats. Acta Physiol. Scand. 143: 287-293.
420. Soares-da-Silva, P., Pestana, M. and Fernandes, M. H. (1993) Involvement of tubular sodium in the formation of dopamine in the human renal cortex. J. Am. Soc. Nephrol. 3: 1591-1599.
421. 1A receptors. Br. J. Pharmacol. 117: 1199-1203.
422. 1 cells. Am. J. Physiol. 274: F243-F251.
423. Sokoloff, P. and Schwartz, J.-C. (1995) Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16: 270-275.
424. Sokoloff, P., Giros, B., Martres, M. P., Bouthenet, M. L. and Schwartz, J. C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146-151.
425. 2 receptor. Eur. J. Pharmacol. 225: 331-337.
426. Sowers, J. R., Crane, P. D., Beck, F. W., McClanahan, M., King, M. E. and Mohanty, P. K. (1984) Relationship between urinary dopamine production and natriuresis after acute intravascular volume expansion with sodium chloride in dogs. Endocrinology 115: 2085-2090.
427. Sowers, J. R., Zemel, M. B., Zemel, P., Beck, F. W. J., Walsh, M. F. and Zawada, E. T. (1988) Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension 12: 485-490.
428. Steinhausen, M., Weis, S., Fleming, J., Dussel, R. and Parekh, N. (1986) Responses of in vivo renal microvessels to dopamine. Kidney Int. 30: 361-370.
429. Stephenson, R. K., Sole, M. J. and Baines, A. D. (1982) Neural and extraneural catecholamine production by rat kidneys. Am. J. Physiol. 242: F261-F266.
430. Stier, C. T., Jr., Cowden, E. A. and Allison, M. E. (1982) Effects of bromocriptine on single nephron and whole-kidney function in rats. J. Pharmacol. Exp. Ther. 220: 366-370.
431. Stote, R. M., Dubb, J. W., Familiar, R. G., Erb, B. B. and Alexander, F. (1983) A new oral renal vasodilator, fenoldopam. Clin. Pharmacol. Ther. 34: 309-315.
432. 1C dopamine receptors from Xenopus laevis. Proc. Natl. Acad. Sci. USA 91: 10536-10540.
433. 4-like receptor. Am. J. Physiol. 271: F391-F400.
434. 1A dopamine receptor (DR) mRNAs are expressed in the rat cortical collecting duct (CCD). FASEB J. 11: A8.
435. 1 receptor encoded by an intronless gene on chromosome 5. Nature 347: 80-83.
436. 1. Nature 350: 614-619.
437. Sunahara, R. K., Dessauer, C. W. and Gilman, A. G. (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36: 461-480.
438. Sunn, N., Woodman, O. L. and Bell, C. (1992) Involvement of dopamine in control of renal blood flow. J. Auton. Nerv. Syst. 41: 113-120.
439. Surmeier, D. J. and Kitai, S. T. (1993) D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons. Prog. Brain Res. 99: 309-324.
440. Suzuki, H., Nakane, H., Kawamura, M., Yoshizawa, M., Takeshita, E. and Saruta, T. (1984) Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney. Am. J. Physiol. 247: E285-E290.
441. Szabo, B., Crass, D. and Starke, K. (1992) Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits. J. Pharmacol. Exp. Ther. 263: 806-815.
442. Takemoto, F., Satoh, T., Cohen, H. T. and Katz, A. I. (1991) Localization of dopamine-1 receptors along the microdissected rat nephron. Pflügers Arch. 419: 243-248.
443. Takemoto, F., Cohen, H. T., Satoh, T. and Katz, A. I. (1992) Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron. Pflügers Arch. 421: 302-306.
444. Takenaka, T., Forster, H. and Epstein, M. (1993) Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435. J. Pharmacol. Exp. Ther. 264: 1154-1159.
445. Tallman, J. F. (1998) NGD 94-1: a specific dopamine-4-receptor antagonist. Adv. Pharmacol. 42: 490-492.
446. 1 receptors. Am. J. Physiol. 256: H626-H629.
447. 4 dopamine receptors in fibroblasts and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268: 495-502.
448. Tang, L., Todd, R. D. and O'Malley, K. L. (1994b) Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270: 475-479.
449. 3 autoreceptors on nigrostriatal neurons analyzed by antisense knock down in vivo. J. Neurosci. 17: 2519-2530.
450. ter Wee, P. M. and Donker, A. J. (1994) Pharmacologic manipulation of glomerular function. Kidney Int. 45: 417-424.
451. Thomas, D., Harris, P. J. and Morgan, T. O. (1988) Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat. J. Hypertens. 6 (Suppl. 4): S449-S451.
452. 1A receptor. Proc. Natl. Acad. Sci. USA 88: 7491-7495.
453. Tiberi, M., Nash, S. R., Bertrand, L., Lefkowitz, R. J. and Caron, M. G. (1996) Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 271: 3771-3778.
454. Undie, A. S. and Friedman, E. (1990) Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J. Pharmacol. Exp. Ther. 253: 987-992.
455. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J. Neurochem. 62: 2045-2048.
456. 1 receptors in renal proximal tubules from normotensive rat and SHR. Am. J. Physiol. 268: F1009-F1016.
457. 2 dopamine receptor interactions in proximal tubules of spontaneously hypertensive rats. Am. J. Physiol. 270: F98-F105.
458. Van Loon, G. R. and Sole, M. J. (1980) Plasma dopamine: source, regulation and significance. Metabolism 29 (Suppl. 1): 1119-1123.
459. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614.
460. Van ToI, H. H., Wu, C. M., Guan, H. C., Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B. and Jovanovic, V. (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358: 149-152.
461. Vieira-Coelho, M. A., Pestana, M. and Soares-da-Silva, P. (1996) High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats. Gen. Pharmacol. 27: 1421-1427.
462. Vlachoyannis, J., Weismuller, G. and Schoeppe, W. (1976) Effects of dopamine on kidney function and on the adenyl cyclase phosphodiesterase system in man. Eur. J. Clin. Invest. 6: 131-137.
463. Vyas, S. J., Eichberg, J. and Lokhandwala, M. F. (1992a) Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex. J. Pharmacol. Exp. Ther. 260: 134-139.
464. Vyas, S. J., Jadhav, A. L., Eichberg, J. and Lokhandwala, M. F. (1992b) Dopamine receptor-mediated activation of phospholipase C is associated with natriuresis during high salt intake. Am. J. Physiol. 262: F494-F498.
465. Wahbe, F., Hagege, J., Loreau, N. and Ardaillou, R. (1982) Endogenous dopamine synthesis and dopa-decarboxylase activity in rat renal cortex. Mol. Cell. Endocrinol. 27: 45-54.
466. 1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol. Pharmacol. 48: 9588-9594.
467. Wang, T. T., Lachance, S., Delalandre, A., Carriere, S. and Chan, J. S. (1996) Dopaminergic receptors and angiotensinogen gene expression in opossum kidney cells. Am. J. Physiol. 271: R519-R527.
468. Wang, Z.-Q., Siragy, H. M., Felder, R. A. and Carey, R. M. (1997) Intrarenal dopamine production and distribution in the rat: physiological control of sodium excretion. Hypertension 29: 228-234.
469. +)-UH232; a microdialysis study. Eur. J. Pharmacol. 242: 151-163.
470. Weber, R. R., McCoy, C. E., Ziemniak, J. A., Frederickson, E. D., Goldberg, L. I. and Murphy, M. B. (1988) Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine 1-receptor agonist, in hypertensive patients. Br. J. Clin. Pharmacol. 25: 17-21.
471. 1B) and its pseudogene. J. Biol. Chem. 266: 22427-22435.
472. Werner, P., Hussy, N., Buell, G., Jones, K. A. and North, R. A. (1996) D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol. Pharmacol. 49: 656-661.
473. Wilk, S., Mizoguchi, H. and Orlowski, M. (1978) Gammaglutamyl dopa: a kidney-specific dopamine precursor. J. Pharmacol. Exp. Ther. 206: 227-232.
474. 4 receptor mediated inhibition of potassium current in neurohypophysial nerve terminals. J. Pharmacol. Exp. Ther. 284: 542-548.
475. 2+ current in neurohypophysial nerve terminals. FASEB J. 12: A748.
476. Woodman, O. L., Rechtman, M. P. and Lang, W. J. (1980) A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney. Arch. Int. Pharmacodyn. Ther. 248: 203-211.
477. Worth, D. P., Harvey, J. N., Brown, J., Worral, A. and Lee, M. R. (1986) Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous γ-L-glutamyl-L-dopa. Br. J. Clin. Pharmacol. 21: 497-502.
478. 1A receptor gene in proximal tubule of rat kidneys. Am. J. Physiol. 264: F280-F285.
479. Yamaguchi, I., Walk, S. F. and Felder, R. A. (1995) Studying the dopaminergic system with transfected receptors. Hypertens. Res. 18 (Suppl. 1): S19-S22.
480. + ATPase activity in murine LTK-cells. Mol. Pharmacol. 49: 373-378.
481. 1A receptors in rat juxtaglomerular cells. Hypertension 29: 962-968.
482. 1B) expression in rat renal microvessels. Pediatr. Res. 37: 374.
483. Yao, L. P., Huque, E., Baraniuk, J. N., Felder, R. A., Carey, R. M. and Jose, P. A. (1997) Dopamine-1 receptor subtype (D1A and D1B) expression in microdissected rat nephron segments. Pediatr. Res. 41: 286A.
484. Yasunari, K., Kohno, M., Murakawa, K., Yokohawa, K., Horio, T. and Takeda, T. (1993) Interaction between a phorbol ester and dopamine DA1 receptors on vascular smooth muscle. Am. J. Physiol. 264: F24-F30.
485. 1 receptors on vascular smooth muscle cells are regulated by glucocorticoid and sodium chloride. Am. J. Physiol. 267: R628-R634.
486. 1 receptor agonist, in anesthetized dogs. Eur. J. Pharmacol. 322: 45-53.
487. Yatsu, T., Uchida, W., Inagaki, O., Tanaka, A. and Takenaka, T. (1997b) Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature. Gen. Pharmacol. 29: 229-232.
488. Yen, T. T., Yu, P., Roeder, H. and Willard, P. W. (1974) A genetic study of hypertension in Okamoto-Aoki spontaneously hypertensive rats. Heredity 33: 309-316.
489. Yingst, D. R. (1988) Modulation of Na,K-ATPase by Ca and intracellular proteins. Annu. Rev. Physiol. 50: 291-303.
490. Yoshimura, M., Yamazaki, H., Takashina, R., Kambara, S., Iyoda, I., Sasaki, S., Takahashi, H., Takeda, K. and Ijichi, H. (1986) The significance of duration of salt loading on cardiovascular response and urinary excretion of catecholamine in rats. Endocrinol. Jpn. 33: 169-175.
491. Yoshimura, M., Kambara, S., Okabayashi, H., Takahashi, H. and Ijichi, H. (1987) Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Clin. Exp. Hypertens. [A] 9: 1141-1157.
492. Yoshimuzi, M., Ohuchi, T., Masuda, Y., Katoh, I. and Oka, M. (1992) Deconjugating activity for sulfoconjugated dopamine in homogenates of organs from dogs. Biochem. Pharmacol. 44: 2263-2265.
493. Young, J. B., Troisi, R. J., Weiss, S. T., Parker, D. R., Sparrow, D. and Landsberg, L. (1992) Relationship of catecholamine excretion to body size, obesity, and nutrient intake in middle-aged and elderly men. Am. J. Clin. Nutr. 56: 827-834.
494. Yu, P.-Y., Asico, L. D., Eisner, G. M. and Jose, P. A. (1995) Differential regulation of renal phospholipase C isoforms by cate-cholamines. J. Clin. Invest. 95: 304-308.
495. 1A receptor in renal proximal tubule cells in spontaneous hypertension. Pediatr. Res. 39: 372A.
496. 1A receptor regulation of phospholipase C isoform expression. J. Biol. Chem. 271: 19503-19508.
497. 1 receptor regulation of phospholipase C (PLC) and adenylyl cyclase (AC) in immortalized renal proximal tubular cells (RPTC) from Wistar-Kyoto (WKY) and spontaneously hypertensive rat (SHR). J. Invest. Med. 44: 307A.
498. Yu, P.-Y., Xu, J., Eisner, G. M. and Jose, P. A. (1997) Differential regulation of protein kinase C isoform by dopamine-1 receptor in spontaneously hypertensive rats. Hypertension 30: 472.
499. Yuan, C., Manunta, P., Chen, S., Hamlyn, J. M., Haddy, F. J. and Pamnani, M. B. (1992) Role of ouabain-like factors in hypertension: effects of ouabain and certain endogenous ouabain-like factors in hypertension. J. Cardiovasc. Pharmacol. 22 (Suppl. 2): S10-S12.
500. 3H]-SCH 23390 labels dopamine D-1 receptor sites in the rat kidney. Eur. J. Pharmacol. 164: 159-162.
501. Zemel, M. B. and Sowers, J. R. (1988) Salt sensitivity and systemic hypertension in the elderly. Am. J. Cardiol. 61: 7H-12H.
502. 1 dopamine receptors. Nature 347: 76-80.